Zobrazeno 1 - 10 of 106 pro vyhledávání: '"Graça M, Dores"'
2
Akademický článek
Survival of adult AML patients treated with chemotherapy in the U.S. population by age, race and ethnicity, sex, calendar-year period, and AML subgroup, 2001–2019Research in context
Autor: Martha S. Linet, Rochelle E. Curtis, Sara J. Schonfeld, Jacqueline B. Vo, Lindsay M. Morton, Graça M. Dores
Publikováno v: EClinicalMedicine, Vol 71, Iss , Pp 102549- (2024)
Summary: Background: Population-based survival studies of adult acute myeloid leukemia (AML) have not simultaneously evaluated age at diagnosis, race and ethnicity, sex, calendar period or AML subtypes/subgroups among chemotherapy-treated patients. M
Externí odkaz: https://doaj.org/article/0d42ebd4cedb4295b9999b5500420644
Zobrazit plný text záznamu
3
Akademický článek
Trends in risk for therapy-related myelodysplastic syndrome/acute myeloid leukemia after initial chemo/immunotherapy for common and rare lymphoid neoplasms, 2000–2018Research in context
Autor: Lindsay M. Morton, Rochelle E. Curtis, Martha S. Linet, Sara J. Schonfeld, Pragati G. Advani, Nicole H. Dalal, Elizabeth C. Sasse, Graça M. Dores
Publikováno v: EClinicalMedicine, Vol 61, Iss , Pp 102060- (2023)
Summary: Background: Historically, survivors of common lymphoid neoplasms (LNs) had increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML). Despite major treatment advances in the treatment of LNs over the last
Externí odkaz: https://doaj.org/article/fd7b22d438214b179e1ee6833ac40ab2
Zobrazit plný text záznamu
4
Akademický článek
Case series of reports of pruritus and sipuleucel-T submitted to the Food and Drug Administration Adverse Event Reporting System
Autor: Graça M. Dores, Silvia Perez-Vilar, Manette T. Niu
Publikováno v: Journal of Pharmaceutical Health Care and Sciences, Vol 5, Iss 1, Pp 1-4 (2019)
Abstract Sipuleucel-T, an autologous active cellular immunotherapy, is indicated for the treatment of asymptomatic or minimally symptomatic castration-resistant prostate cancer. The U.S. Food and Drug Administration Adverse Event Reporting System (FA
Externí odkaz: https://doaj.org/article/94bdf3f6f7f446579fe5e898d2cd2c0f
Zobrazit plný text záznamu
5
Akademický článek
Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes
Autor: Megan M. Herr, Sara J. Schonfeld, Graça M. Dores, Eric A. Engels, Margaret A. Tucker, Rochelle E. Curtis, Lindsay M. Morton
Publikováno v: Blood Advances, Vol 3, Iss 13, Pp 1961-1969 (2019)
Abstract: Infectious agents have been identified in the etiology of certain non-Hodgkin lymphoma (NHL) subtypes and solid tumors. The impact of this shared etiology on risk for second cancers in NHL survivors has not been comprehensively studied. We
Externí odkaz: https://doaj.org/article/5740ab443da74f24bcc622eba33ee568
Zobrazit plný text záznamu
8
Akademický článek
Acute myocardial infarction: Development and application of an ICD-10-CM-based algorithm to a large U.S. healthcare claims-based database.
Autor: Patrick Saunders-Hastings, Sze Wing Heong, Jenny Srichaikul, Hui-Lee Wong, Azadeh Shoaibi, Kinnera Chada, Timothy A Burrell, Graça M Dores
Publikováno v: PLoS ONE, Vol 16, Iss 7, p e0253580 (2021)
BackgroundHealthcare administrative claims data hold value for monitoring drug safety and assessing drug effectiveness. The U.S. Food and Drug Administration Biologics Effectiveness and Safety Initiative (BEST) is expanding its analytical capacity by
Externí odkaz: https://doaj.org/article/2e24129f2a724772aedda64181cb51c8
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje